FDA Approves CEFIXIME — Aurobindo Pharma Limited

# FDA Approves Aurobindo Pharma's Generic Cefixime Oral Formulation The U.S. FDA has approved Aurobindo Pharma Limited's abbreviated new drug application (ANDA217607) for generic cefixime oral tablets, expanding the competitive landscape in the oral cephalosporin antibiotic market and potentially increasing pricing pressure on existing branded and generic alternatives. The approval strengthens Aurobindo's presence in the U.S. generic pharmaceuticals market while providing healthcare providers with another cost-effective treatment option for bacterial infections.